Who invested in Epicore Biosystems?
Epicore Biosystems's investors include Alumni Ventures, National Institutes of Health, Chevron Technology Ventures and Pegasus Tech Ventures.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$6.0Mraised across 1 round since 2025, from 1 source
Source recordedSEC filing: $26M sold, first sale Dec 2024
From Epicore Biosystems's own website: 1 founder, 22 on the team.
And 4 more on the team.
AdvisersLaura LangStephen Schweich
Epicore Biosystems's investors include Alumni Ventures, National Institutes of Health, Chevron Technology Ventures and Pegasus Tech Ventures.
Epicore Biosystems has raised $6.0M across 1 round since 2025.
Epicore Biosystems's most recent round was a Series B of $6.0M in May 2025.
Its most recent round, $6.0M in May 2025, is also its largest on record.
Epicore Biosystems's first round on record, in May 2025, was backed by Alumni Ventures, National Institutes of Health and Chevron Technology Ventures and 1 others.
Epicore Biosystems's latest named round is a Series B, in May 2025.
Epicore Biosystems is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.